| 000 | 01325 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513050406.0 | ||
| 264 | 0 | _c19950405 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWillems, F | |
| 245 | 0 | 0 |
_aInduction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cFeb 1995 |
||
| 300 |
_a1425-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aClonal Anergy |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 |
_aInterleukin-10 _xbiosynthesis |
| 650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xmetabolism |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aAndris, F | |
| 700 | 1 | _aAbramowicz, D | |
| 700 | 1 | _aPiérard, G | |
| 700 | 1 | _aWissing, M | |
| 700 | 1 | _aLeo, O | |
| 700 | 1 | _aGoldman, M | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 27 _gno. 1 _gp. 1425-7 |
|
| 999 |
_c7878271 _d7878271 |
||